EUVIMEDEUVIMED entdecken
Crossref

Correlation between the systemic immune inflammation index and risk of psoriasis: results from NHANES

Jingyi Ma, Xin Sun, Ze Wu, Ruiqun Qi, Jun Niu

European Journal of Dermatology · 2024

DOI: 10.1684/ejd.2024.4610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Dermatology, 2024. Verfasst von Jingyi Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, General Hospital of Northern Theatre Command, Shenyang, Liaoning 110001, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Psoriasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The systemic immune inflammation index (SII) is an effective indicator of systemic inflammatory status. As psoriasis patients present with systemic involvement, we assessed whether SII is associated with psoriasis in adults. We used data from the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2006 and 2009 to 2014. The study used a multistage sampling design that nationally represents the US population. The main outcome was the prevalence of psoriasis. SII was calculated as platelet count × neutrophil count/lymphocyte count and transformed into log2SII. Sampling weights were calculated according to the guidelines of NHANES. The cohort consisted of 13,300 participants, aged 20-59, who provided responses to their psoriasis status. Among the adults included in this study were 358 with psoriasis and 12,942 without psoriasis. Based on multivariate analysis adjusted for multiple covariates, the highest quartile of log2SII positively correlated with psoriasis relative to the lowest quartile. The subgroup analyses showed that participants in quartile 4 correlated with an increased risk of psoriasis among those aged 40 to 59 years, and among those with obesity or metabolic syndrome. Based on sensitivity analyses, the association between log2SII and psoriasis remained after excluding potential systemic medication use. Based on this cross-sectional study, SII was shown to be associated with psoriasis in the US adult population. Longitudinal monitoring of systemic inflammatory status in psoriasis patients may be necessary to prevent the recurrence of psoriasis, especially for those with obesity or metabolic syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromePsoriasisAdultHumansNutrition SurveysCross-Sectional StudiesInflammationObesity

Stichwörter der Autor:innen

NHANESmetabolic syndromeobesitypsoriasissystemic immune inflammation index

Autor:innen und Institutionen

  • Department of Dermatology, General Hospital of Northern Theatre Command, Shenyang, Liaoning 110001, China.
  • Department of Oncology, Tangdu Hospital, The Air Force Medical University, Shaanxie Xi'ane 710038, China.
  • Department of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.

Zitieren

APA

Ma, J., Sun, X., Wu, Z., Qi, R., & Niu, J. (2024). Correlation between the systemic immune inflammation index and risk of psoriasis: results from NHANES. European Journal of Dermatology. https://doi.org/10.1684/ejd.2024.4610

Vancouver

Ma J, Sun X, Wu Z, Qi R, Niu J. Correlation between the systemic immune inflammation index and risk of psoriasis: results from NHANES. European Journal of Dermatology. 2024. doi:10.1684/ejd.2024.4610

BibTeX
@article{Ma2024,
  author = {Ma, Jingyi and Sun, Xin and Wu, Ze and Qi, Ruiqun and Niu, Jun},
  title = {Correlation between the systemic immune inflammation index and risk of psoriasis: results from NHANES},
  journal = {European Journal of Dermatology},
  year = {2024},
  doi = {10.1684/ejd.2024.4610}
}
Kostenlos starten →